跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,943 条关于
“Levodopa-Induced Dyskinesia”
全部
12,943
临床试验
10,721
药物
186
机构
3
资讯
2,033
去年
EMA Waives Pediatric Trial Requirements for Mesdopetam in Parkinson's Disease
去年
EMA and FDA Align on Phase III Program for IRLAB's Mesdopetam in Parkinson's Disease
去年
Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia
去年
Celon Pharma's PDE10A Inhibitor Shows Significant Promise in Phase 2 Trial for Parkinson's Disease Dyskinesia
11个月前
FDA Clears Celon Pharma's Novel PDE10A Inhibitor CPL-936 for Phase 3 Schizophrenia Trials
去年
Trevi Therapeutics' Haduvio Shows Promise for IPF-Related Cough Treatment, Receives Buy Rating
6个月前
Lundbeck Reports Positive Phase 1b Results for Lu AF28996 in Advanced Parkinson's Disease
去年
MeiraGTx's AAV-GAD Gene Therapy Shows Promise in Parkinson's Disease Phase I/II Trial
去年
IRLAB's Mesdopetam Advances to Phase III for Parkinson's Disease Dyskinesias
去年
NLX-112 Receives Orphan Drug Designation in Europe for Spinocerebellar Ataxia
第 1 页，共 204 页
上一页
下一页
